Literature DB >> 19460104

Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study.

S Hervé1, L Beaugerie, Y Bouhnik, G Savoye, J-F Colombel, F Dyard, I Hourmand-Ollivier, T Dao, M Vial, E Lerebours.   

Abstract

It has been suspected that there is an epidemiological link between irritable bowel syndrome (IBS) and ischaemic colitis (IC). We performed a retrospective case-control study to compare the frequency of IBS in patients hospitalized for IC compared with that of patients with peptic ulcer bleeding. Cases were patients with a first episode of IC and controls were patients with a first episode of peptic ulcer bleeding, matched to cases for sex and 10-year age-class. Diagnosis of IBS was based on medical information extracted from hospital medical files and a standard self-questionnaire. The association between IBS and IC was tested using Mc Nemar's paired odds ratio (OR); confidence interval at 95% (CI 95%) was calculated; Mantel-Haenzel's Chi(2) was applied. A total of 113 cases and 113 matched controls were studied. There were 37 males and 76 females and the mean age was 69 +/- 15 years in each group. The prevalence of IBS in cases was 16.9%vs 1.8% in controls. The risk of IBS was 11.05 times higher among cases than in controls (P < 0.001); CI 95%: (2.45-49.74). A total of 87 pairs with complete data were used for OR calculation. The risk of IBS was 7.5 times higher in cases than in controls (P = 0.002); CI 95%: (1.72-32.80). This case-control study shows that IBS is more frequent in IC patients than in controls.

Entities:  

Mesh:

Year:  2009        PMID: 19460104     DOI: 10.1111/j.1365-2982.2009.01333.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron.

Authors:  Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.

Authors:  Kenneth Tong; Jean Paul Nicandro; Reshma Shringarpure; Emil Chuang; Lin Chang
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

Review 3.  The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.

Authors:  James H Lewis
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

4.  A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis.

Authors:  Siddhant Yadav; Maneesh Dave; Jithinraj Edakkanambeth Varayil; W Scott Harmsen; William J Tremaine; Alan R Zinsmeister; Seth R Sweetser; L Joseph Melton; William J Sandborn; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-12       Impact factor: 11.382

5.  Update on the Diagnosis and Management of Colon Ischemia.

Authors:  Ann D Flynn; John F Valentine
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.